Scientific KnowledgeAnimal study (in vivo)MouseAnimal study (in vivo)Mouse
Chen Laboratory
Harvard Medical School / Massachusetts Eye and Ear
Gene therapy, AAV vector engineering, and drug/gene delivery to the inner ear.
Explore connections· click any item to explore
Researchers1
Papers (2)
Identification of Adeno-Associated Viral Vectors That Target Neonatal and Adult Mammalian Inner Ear Cell Subtypes.
Human gene therapy · 2016
Screened 12 AAV serotypes in the mouse inner ear to map which vectors best reach hair cells and supporting cells, foundational work for cochlear gene therapy delivery.
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo.
Nature communications · 2023
Liposome-delivered CRISPR-Cas9 selectively cuts a dominant deafness allele in the mouse cochlea, rescuing hair cells and hearing, including in mice with two independent deafness mutations at once.